160 related articles for article (PubMed ID: 18922443)
1. Con: The role of recombinant factor VIIa in the control of bleeding after cardiac surgery.
Al-Ruzzeh S; Ibrahim K; Navia JL
J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):783-5. PubMed ID: 18922443
[No Abstract] [Full Text] [Related]
2. Pro: The role of recombinant factor VIIa in cardiac surgery.
Karkouti K; Beattie WS
J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):779-82. PubMed ID: 18922442
[No Abstract] [Full Text] [Related]
3. Recombinant activated factor VII in cardiac surgery--will we ever know for sure?
Silver DA; D'Ambra MN
Crit Care Med; 2007 Jul; 35(7):1782-3. PubMed ID: 17581365
[No Abstract] [Full Text] [Related]
4. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
[TBL] [Abstract][Full Text] [Related]
5. Caution with the use of recombinant activated factor VII in treating postoperative hemorrhage in cardiac surgery.
Al-Ruzzeh S; Mahmoud A; Shah S; O'Regan D
Ann Thorac Surg; 2007 Jan; 83(1):355; author reply 355-6. PubMed ID: 17184710
[No Abstract] [Full Text] [Related]
6. Systemic venous thrombosis after recombinant factor VIIa in the control of bleeding after cardiac surgery.
Mahmoud A; Al-Ruzzeh S; McKeague H; Cross M
Tex Heart Inst J; 2007; 34(4):485-8. PubMed ID: 18172537
[TBL] [Abstract][Full Text] [Related]
7. Vascular injury and thrombotic potential: a note of caution about recombinant factor VIIa.
Mazer CD; Leong-Poi H; Mahoney J; Latter D; Strauss BH; Teitel JM
Semin Cardiothorac Vasc Anesth; 2007 Dec; 11(4):261-4. PubMed ID: 18270189
[TBL] [Abstract][Full Text] [Related]
8. Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery.
Singh SP; Chauhan S; Choudhary M; Vasdev S; Talwar S
Asian Cardiovasc Thorac Ann; 2012 Feb; 20(1):19-23. PubMed ID: 22371937
[TBL] [Abstract][Full Text] [Related]
9. Caveat against the use of activated recombinant factor VII for intractable bleeding in cardiac surgery.
Dietrich W; Spannagl M
Anesth Analg; 2002 May; 94(5):1369-70; author reply 1370-1. PubMed ID: 11973226
[No Abstract] [Full Text] [Related]
10. Recombinant factor VIIa (NovoSeven RT) use in high risk cardiac surgery.
Chapman AJ; Blount AL; Davis AT; Hooker RL
Eur J Cardiothorac Surg; 2011 Dec; 40(6):1314-8; discussion 1318-9. PubMed ID: 21601468
[TBL] [Abstract][Full Text] [Related]
11. Continuous infusion of recombinant factor VIIa: continue or not?
Ewenstein BM
Thromb Haemost; 2001 Oct; 86(4):942-4. PubMed ID: 11686349
[No Abstract] [Full Text] [Related]
12. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
[TBL] [Abstract][Full Text] [Related]
13. Successful control of severe postoperative bleeding with recombinant factor VIIa in a case of refractory idiopathic thrombocytopenic purpura.
Aguilar C; Lucía JF
Am J Hematol; 2007 Mar; 82(3):246-7. PubMed ID: 16924645
[No Abstract] [Full Text] [Related]
14. Dosing factor VIIa (recombinant) in nonhemophiliac patients with bleeding after cardiac surgery.
Johnson SJ; Ross MB; Moores KG
Am J Health Syst Pharm; 2007 Sep; 64(17):1808-12. PubMed ID: 17724361
[TBL] [Abstract][Full Text] [Related]
15. Low-dose recombinant factor VIIa in the management of uncontrolled postoperative hemorrhage in cardiac surgery patients.
van de Garde EM; Bras LJ; Heijmen RH; Knibbe CA; van Dongen EP; Wiltink EH; Biesma DH
J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):573-5. PubMed ID: 16884993
[No Abstract] [Full Text] [Related]
16. Use of recombinant activated factor VIIa for nonsurgical, refractory bleeding in neonatal cardiac surgery patients: case series.
Camkiran A; Pirat A; Zeyneloglu P; Ozkan M; Arslan G
J Cardiothorac Vasc Anesth; 2013 Apr; 27(2):e14-5. PubMed ID: 23507020
[No Abstract] [Full Text] [Related]
17. Letter by Al-Ruzzeh and Navia regarding article, "Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery".
Al-Ruzzeh S; Navia JL
Circulation; 2010 Mar; 121(9):e234. PubMed ID: 20212289
[No Abstract] [Full Text] [Related]
18. Factor VII for excessive bleeding following congenital heart disease surgery.
Changlani DK; Devendaran V; Murmu UC; Ganesan S; Varghese R; Kumar RS
Asian Cardiovasc Thorac Ann; 2012 Apr; 20(2):120-5. PubMed ID: 22499956
[TBL] [Abstract][Full Text] [Related]
19. Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score-matched case-control analysis.
Karkouti K; Beattie WS; Wijeysundera DN; Yau TM; McCluskey SA; Ghannam M; Sutton D; van Rensburg A; Karski J
Transfusion; 2005 Jan; 45(1):26-34. PubMed ID: 15647015
[TBL] [Abstract][Full Text] [Related]
20. A role for very low-dose recombinant activated factor VII in refractory bleeding after cardiac surgery: Lessons from an observational study.
Hoffmann T; Assmann A; Dierksen A; Roussel E; Ullrich S; Lichtenberg A; Albert A; Sixt S
J Thorac Cardiovasc Surg; 2018 Oct; 156(4):1564-1573.e8. PubMed ID: 29884487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
